Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006133 · ClinicalTrials.gov registry record · NA
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
- 970
- Enrollment target
NCT00006133 is a NA study that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 970 participants.
The verdict
NCT00006133, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
- 970 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic estrogens and progestins on disease activity in premenopausal women with inactive, stable, or moderate systemic lupus erythematosus (SLE). II. Determine the effect of hormone replacement therapy with conjugated estrogens and progestins on disease activity in postmenopausal women with inactive, stable, or moderate SLE.
Interventions
- DRUG medroxyprogesterone
- DRUG ethinyl estradiol
- DRUG estradiol
- DRUG norethindrone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 970 participants |
| Start Date | 2000-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006133
The ClinicalTrials.gov registry entry for NCT00006133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 970 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which medroxyprogesterone is the first listed.
NCT00006133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006133 about?
NCT00006133 is a clinical study titled "Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus". OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic estrogens and progestins on disease activity in premenopausal women with inactive, stable, or moderate systemic lupus erythematosus (SLE). II. Determine the effect of hormone replacement therapy with conjugated...
What is the current status of trial NCT00006133?
This trial is currently completed. It is a NA study. The enrollment target is 970 participants. The study started on 2000-06.
What interventions are being tested in trial NCT00006133?
The interventions under investigation include: medroxyprogesterone (DRUG), ethinyl estradiol (DRUG), estradiol (DRUG), norethindrone (DRUG).
Who is sponsoring clinical trial NCT00006133?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.